Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

11.42
Delayed Data
As of Aug 28
 +0.21 / +1.87%
Today’s Change
7.85
Today|||52-Week Range
16.83
-6.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues3.2M5.4M6.8M25.8M
 
 
 
 
 
Cost of Goods Sold0.004.0K30.0K393.0K
 
 
 
 
Depreciation And Amortization40.0K40.0K45.0K49.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.2M5.4M6.8M25.4M
 
 
 
 
 
General Expenses14.8M20.6M21.2M20.1M
 
 
 
 
 
Research And Development13.0M18.5M17.1M16.5M
 
 
 
 
 
Total Operating Expenses14.8M20.6M21.3M20.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.6M-15.2M-14.4M5.3M
 
 
 
 
 
Extraordinary Credit4.1M4.8M464.0K749.0K
 
 
 
 
 
Interest Expense On Debt1.2M1.3M1.3M1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.7M-11.7M-15.2M4.9M
 
 
 
 
 
Net Income-8.7M-11.7M-15.2M4.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.8M71.9M72.3M72.6M
 
 
 
 
 
Shares To Calculate EPS Diluted71.8M71.9M72.3M76.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.16-$0.21$0.06
 
 
 
 
 
EPS Diluted-$0.12-$0.16-$0.21$0.06